Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
6.23
+0.77 (14.10%)
Nov 5, 2024, 4:00 PM EST - Market closed
Orchestra BioMed Holdings Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 |
Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -55.58 | -49.12 | -33.61 | -23.01 | -21.36 |
Depreciation & Amortization | 0.29 | 0.29 | 0.22 | 0.18 | 0.14 |
Other Amortization | 0.04 | 0.11 | 0.16 | 0.22 | - |
Loss (Gain) From Sale of Investments | -2.55 | -3.8 | -1.63 | 0.29 | 2.93 |
Stock-Based Compensation | 9.78 | 7.63 | 3.41 | 0.3 | 0.22 |
Other Operating Activities | 1.71 | 2.08 | 2.6 | -0.03 | 0.07 |
Change in Accounts Receivable | 0.09 | -0 | 0.03 | 0.05 | -0.08 |
Change in Inventory | 0.11 | 0.13 | -0.21 | 0 | -0.03 |
Change in Accounts Payable | 3.61 | 0.15 | 3.35 | 1.08 | -2.61 |
Change in Unearned Revenue | -1.48 | -2.11 | -2.86 | 1.48 | -5.17 |
Change in Other Net Operating Assets | -0.59 | -1.47 | -0.76 | 0.03 | -0.31 |
Operating Cash Flow | -44.58 | -46.13 | -29.29 | -19.43 | -26.18 |
Capital Expenditures | -0.13 | -0.08 | -0.59 | -0.27 | -0.54 |
Investment in Securities | 62.51 | 10.77 | -63.53 | 13.5 | 27.69 |
Other Investing Activities | - | - | - | -0.21 | -0.19 |
Investing Cash Flow | 62.38 | 10.69 | -64.12 | 13.02 | 26.97 |
Long-Term Debt Issued | - | - | 10 | - | 10 |
Long-Term Debt Repaid | - | -10.85 | -6.45 | -4 | - |
Net Debt Issued (Repaid) | -10.85 | -10.85 | 3.55 | -4 | 10 |
Issuance of Common Stock | 0.35 | 0.25 | 0.2 | 0.01 | - |
Other Financing Activities | - | 56.81 | -10.33 | - | - |
Financing Cash Flow | -10.5 | 46.22 | 103.26 | -3.99 | 10 |
Net Cash Flow | 7.3 | 10.78 | 9.85 | -10.41 | 10.78 |
Free Cash Flow | -44.71 | -46.21 | -29.88 | -19.7 | -26.72 |
Free Cash Flow Margin | -2150.41% | -1674.09% | -845.74% | - | -468.56% |
Free Cash Flow Per Share | -1.26 | -1.39 | -1.99 | -9.33 | -13.27 |
Cash Interest Paid | 0.4 | 1.12 | 1.37 | 0.39 | - |
Levered Free Cash Flow | -22.91 | -32.17 | -10.06 | -13.86 | - |
Unlevered Free Cash Flow | -22.95 | -32.28 | -10.22 | -13.5 | - |
Change in Net Working Capital | -3.54 | 7.92 | -7.15 | 0.08 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.